KittyHawk Ventures

KittyHawk Ventures is an early-stage venture fund with limited public information about fund size, partner team, and detailed thesis, operating as a small institutional investor in seed and pre-seed software companies. Healthcare exposure cannot be characterized confidently from public sources; founders should ask for prior healthcare investments and reference at least two portfolio CEOs before progressing. AI focus is undeclared. Plausible check sizes are $100K to $750K at seed and pre-seed, typically as a co-investor rather than a lead. Founders best suited are seed-stage CEOs raising priced rounds with an institutional lead, who want a small high-conviction check from a partner willing to be hands-off but available for warm introductions. Founders who do not fit include therapeutics, devices, growth-stage rounds, and capital-intensive businesses. Geographic preference appears to be US with no obvious regional bias. The entry path is warm introduction through a portfolio CEO or a co-investor, with LinkedIn outreach to a principal as a secondary option for founders with strong traction and a clear ask. Founders should not expect KittyHawk to lead, and the firm is best deployed as supplemental capital alongside a healthcare-native anchor. Founders looking for healthcare-specific operational support, regulatory expertise, or significant follow-on capital should plan to lead with a different investor and use KittyHawk only as a small supplemental check after an anchor is committed. Validate fund pacing and active deployment before progressing.